Effects of augmentation of liver regeneration recombinant plasmid on rat hepatic fibrosis

World Journal of Gastroenterology

Volumn 11, Issue 16, 2005, Pages 2438-2443

  Li, Qing ^a   Liu, Dian Wu ^a   Zhang, Li Mei ^a   Zhu, Bing ^a   He, Yu Tong ^a   Xiao, Yong Hong ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Augmentation of liver regeneration; Gene therapy; Hepatic fibrosis; Rat; Tissue inhibitor of metalloproteinases 1

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA ACTIN; COLCHICINE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; HYALURONIC ACID; LAMININ; MESSENGER RNA; PROCOLLAGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; EUKARYOTE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER REGENERATION; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RANDOMIZATION; RAT; RAT STRAIN; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

EID: 18744415461     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i16.2438     Document Type: Article

References (36)

1. Miyazawa K, Moriyama M, Mikuni M, Matsumura H, Aoki H, Shimizu T, Yamagami H, Kaneko M, Shioda A, Tanaka N, Arakawa Y. Analysis of background factors and evaluation of a population at high risk of hepatocellular carcinoma. Intervirology 2003; 46: 150-156
2. Nagao Y, Fukuizumi K, Kumashiro R, Tanaka K, Sata M. The prognosis for life in an HCV hyperendemic area. Gastroenterology 2003; 125: 628-629
3. Lee HS, Huang GT, Chen CH, Chiou LL, Lee CC, Yang PM, Chen DS, Sheu JC. Less reversal of liver fibrosis after prolonged carbon tetrachloride injection. Hepatogastroenterology 2001; 48: 1312-1315
4. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250
5. Riley TR 3rd, Bhatti AM. Preventive strategies in chronic liver disease: part II. Cirrhosis. Am Fam Physician 2001; 64: 1735-1740
6. Brenner DA. Signal transduction during liver regeneration. J Gastroenterol Hepatol 1998; 13(Suppl): S93-95
7. Garcia-Banuelos J, Siller-Lopez F, Miranda A, Aguilar LK, Aguilar-Cordova E, Armendariz-Borunda J. Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion. Gene Ther 2002; 9: 127-134
8. Salgado S, Garcia J, Vera J, Siller F, Bueno M, Miranda A, Segura A, Grijalva G, Segura J, Orozco H, Hernandez-Pando R, Fafutis M, Aguilar LK, Aguilar-Cordova E, Armendariz-Borunda J. Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy. Mol Ther 2000; 2: 545-551
9. Rudolph KL, Chang S, Millard M, Schreiber-Agus N, DePinho RA. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 2000; 287: 1253-1258
10. Ukei T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Takahashi H, Okamoto E, Fujimoto J. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999; 5: 226-230
11. Ueno H, Sakamoto T, Nakamura T, Qi Z, Astuchi N, Takeshita A, Shimizu K, Ohashi H. A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum Gene Ther 2000; 11: 33-42
12. Hagiya M, Francavilla A, Polimenoe L, Ihara I, Sakai H, Seki T, Shimonishi M, Porter KA, Starzl TE. Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci USA 1994; 91: 8142-8146
13. Tanigawa K, Sakaida I, Masuhara M, Hagiya M, Okita K. Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer(NK) cell activity in human liver diseases. J Gastroenterol 2000; 35: 112-119
14. Polimeno L, Capuano F, Marangi LC, Margiotta M, Lisowsky T, Ierardi E, Francavilla R, Francavilla A. The augmenter of liver regeneration induces mitochondrial gene expression in rat liver and enhances oxidative phosphorylation capacity of liver mitochondria. Dig Liver Dis 2000; 32: 510-517
15. Yang Y, Wang A, Zhou P, Wang Q, Wei H, Wu Z, He F. Protective effect of recombinant human augmenter of liver regeneration on CCl4-induced hepatitis in mice. Chin Med J 1998; 111: 625-629
16. Zhang LM, Liu DW, Yang J, Li Q. Construction of eukaryotic express plasmid of rat augmenter of liver regeneration gene and effect on acute hepatic failure in rats. Hebei Yike Daxue Xuebao 2004; 25: 68-70
17. Lee SJ, Kim YG, Kang KW, Kim CW, Kim SG. Effects of colchicine on liver functions of cirrhotic rats: beneficial effects result from stellate cell inactivation and inhibition of TGF betal expression. Chem Biol Interact 2004; 147: 9-21
18. Das D, Pemberton PW, Burrows PC, Gordon C, Smith A, McMahon RF, Warnes TW. Antioxidant properties of colchicine in acute carbon tetrachloride induced rat liver injury and its role in the resolution of established cirrhosis. Biochim Biophys Acta 2000; 1502: 351-362
19. Peng D, Qian C, Sun Y, Barajas MA, Prieto J. Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents. J Hepatol 2000; 32: 975-985
20. Shiga A, Shirota K, Nishita T, Nomura Y. Study on the pathogenesis of porcine serum-induced liver fibrosis in rats with special reference to the effects of hypertension. J Vet Med Sci 1998; 60: 29-34
21. Giorda R, Hagiya M, Seki T, Shimonishi M, Sakai H, Michaelson J, Francavilla A, Starzl TE, Trucco M. Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol Med 1996; 2: 97-108
22. Polimeno L, Margiotta M, Marangi L, Lisowsky T, Azzarone A, Ierardi E, Frassanito MA, Francavilla R, Francavilla A. Molecular mechanisms of augmenter of liver regeneration as immunoregulator: its effect on interferon-gamma expression in rat liver. Dig Liver Dis 2000; 32: 217-225
23. Vaillant B, Chiaramonte MG, Cheever AW, Soloway PD, Wynn TA. Regulation of hepatic fibrosis and extracellular matrix genes by the th response: new insight into the role of tissue inhibitors of matrix metalloproteinases. J Immunol 2001; 167: 7017-7026
24. Herbst H, Wege T, Milani S, Pellegrini G, Orzechowski HD, Bechstein WO, Neuhaus P, Gressner AM, Schuppan D. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol 1997; 150: 1647-1659
25. Ulrich D, Lichtenegger F, Eblenkamp M, Repper D, Pallua N. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants. Plast Reconstr Surg 2004; 114: 229-236
26. Li YL, Sato M, Kojima N, Miura M, Senoo H. Regulatory role of extracellular matrix components in expression of matrix metalloproteinases in cultured hepatic stellate cells. Cell Struct Funct 1999; 24: 255-261
27. Alcolado R, Arthur MJ, Iredale JP. Pathogensis of liver fibrosis. Clin Sci 1997; 92: 103-112
28. Iredale JP. Tissue inhibitors of metalloproteinases in liver fibrosis. Int J Biochem Cell Biol 1997; 29: 43-54
29. Arthur MJ, Iredale JP, Mann DA. Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease. Alcohol Clin Exp Res 1999; 23: 940-943
30. Flisiak R, Maxwell P, Prokopowicz D, Timms PM, Panasiuk A. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1-possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis. Hepatogastroenterology 2002; 49: 1369-1372
31. Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS, Fukui H. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 2000; 32: 1248-1254
32. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur W. Mechanisms of spontaneous resolution of rat liver fibrosis, Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Chin Invest 1998; 102: 538-549
33. Louis H, Le Moine A, Quertinmont E, Peny MO, Geerts A, Goldman M, Le Moine O, Deviere J. Repeated concanavalin A challenge in mice induces an interleukin 10-producing phenotype and liver fibrosis. Hepatology 2000; 31: 381-390
34. Kovalovich K, DeAngelis RA, Li W, Furth EE, Ciliberto G, Taub R. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 2000; 31: 149-159
35. Arthur MJ. Collagenases and liver fibrosis. J Hepatol 1995; 22 (2 Suppl): s43-48
36. Arthur MJ. Degradation of matrix proteins in liver fibrosis. Pathol Res Pract 1994; 190: 825-833